$IDEX
IDEANOMICS, INC. Stock $idex

$idex Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000162828023027525 Filed on August 04, 2023

Income Statement

Concept	2023 Q3	2023 Q1	2022 Q1
Revenue	$665.0K	$10.56M	$25.39M
YoY Change	-97.26%	-58.4%	-22.37%
Cost Of Revenue	$2.118M	$11.13M	$25.37M
YoY Change	-91.51%	-56.13%	16.02%
Gross Profit	-$1.453M	-$569.0K	$20.00K
YoY Change	120.49%	-2945.0%	-99.82%
Gross Profit Margin	-218.5%	-5.39%	0.08%
Selling, General & Admin	$8.146M	$46.25M	$37.10M
YoY Change	-78.4%	24.67%	209.0%
% of Gross Profit			185475.0%
Research & Development	$1.540M	$4.625M	$1.014M
YoY Change	81.39%	356.11%	10040.0%
% of Gross Profit			5070.0%
Depreciation & Amortization	$500.0K	$4.831M	$300.0K
YoY Change	-16.67%	1510.33%	-73.45%
% of Gross Profit			1500.0%
Operating Expenses	$68.69M	$55.38M	$39.34M
YoY Change	66.68%	40.76%	65.28%
Operating Profit	-$70.14M	-$55.95M	-$39.32M
YoY Change	67.53%	42.28%	203.36%
Interest Expense	$1.366M	-$1.009M	$579.0K
YoY Change	199.56%	-274.27%	38.85%
% of Operating Profit
Other Income/Expense, Net	$9.560M	$2.382M	$191.0K
YoY Change	271.41%	1147.12%	-9650.0%
Pretax Income	-$63.10M	-$86.09M	-$28.13M
YoY Change	62.53%	206.03%	106.05%
Income Tax	-$900.0K	-$2.985M	-$400.0K
% Of Pretax Income
Net Earnings	-$63.01M	-$84.32M	-$28.51M
YoY Change	68.4%	195.72%	4875.92%
Net Earnings / Revenue	-9474.74%	-798.31%	-112.29%
Basic Earnings Per Share	-$5.39	-$0.12	-$0.06
Diluted Earnings Per Share	-$5.39	-$0.12	-$0.06
COMMON SHARES
Basic Shares Outstanding	1.384B shares	787.0M shares	497.4M shares
Diluted Shares Outstanding	11.69M shares	731.0M shares	497.4M shares

Balance Sheet

Concept	2023 Q3	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.884M	$18.88M	$174.7M
YoY Change	-92.52%	-89.19%	-52.92%
Cash & Equivalents	$1.900M	$18.88M	$170.8M
Short-Term Investments			$3.917M
Other Short-Term Assets	$5.046M	$20.72M	$4.703M
YoY Change	-11.05%	340.57%	881.84%
Inventory	$16.78M	$27.35M	$21.86M
Prepaid Expenses	$6.863M	$10.54M	$26.07M
Receivables	$3.066M	$7.977M	$3.393M
Other Receivables	$90.00K	$583.0K	$56.50M
Total Short-Term Assets	$46.16M	$75.51M	$289.8M
YoY Change	-72.85%	-73.95%	-25.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.13M	$31.04M	$5.547M
YoY Change	9.42%	459.58%	779.08%
Goodwill	$37.25M	$51.37M	$75.75M
YoY Change	-45.78%	-32.19%	48.29%
Intangibles	$39.98M	$156.1M	$89.58M
YoY Change	-49.16%	74.24%	-3.18%
Long-Term Investments	$0.00	$0.00	$15.57M
YoY Change	-100.0%	-100.0%	-2.8%
Other Assets	$2.866M	$2.974M	$1.537M
YoY Change	132.06%	93.49%	170.12%
Total Long-Term Assets	$105.1M	$241.5M	$214.3M
YoY Change	-47.51%	12.67%	20.19%
TOTAL ASSETS
Total Short-Term Assets	$46.16M	$75.51M	$289.8M
Total Long-Term Assets	$105.1M	$241.5M	$214.3M
Total Assets	$151.3M	$317.0M	$504.2M
YoY Change	-59.15%	-37.13%	-11.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$56.27M	$57.60M	$16.18M
YoY Change	147.0%	255.96%	62.17%
Accrued Expenses	$2.436M	$21.99M	$10.33M
YoY Change	-79.35%	112.92%	78.07%
Deferred Revenue	$2.900M	$2.498M	$8.370M
YoY Change	-18.08%	-70.16%
Short-Term Debt	$10.24M	$8.237M	$3.945M
YoY Change	322.57%	108.8%	338.33%
Long-Term Debt Due	$6.149M	$1.650M	$58.38M
YoY Change	-35.93%	-97.17%	-27.39%
Total Short-Term Liabilities	$109.3M	$128.1M	$111.0M
YoY Change	76.47%	15.45%	-8.11%
LONG-TERM LIABILITIES
Long-Term Debt	$1.673M	$1.894M	$1.850M
YoY Change	7.31%	2.38%
Other Long-Term Liabilities	$1.116M	$78.03M	$632.0K
YoY Change	44.94%	12246.68%	-46.21%
Total Long-Term Liabilities	$2.789M	$79.93M	$2.482M
YoY Change	19.75%	3120.19%	111.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$109.3M	$128.1M	$111.0M
Total Long-Term Liabilities	$2.789M	$79.93M	$2.482M
Total Liabilities	$128.2M	$215.3M	$138.1M
YoY Change	48.29%	55.91%	-1.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.050B	-$951.1M	-$634.3M
YoY Change	47.95%	49.95%	82.55%
Common Stock	$1.499M	$916.0K	$498.0K
YoY Change	189.94%	83.94%	18.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.43M	$101.7M	$338.2M
YoY Change
Total Liabilities & Shareholders Equity	$151.3M	$317.0M	$504.2M
YoY Change	-59.15%	-37.13%	-11.53%

Cashflow Statement

Concept	2023 Q3	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$63.01M	-$84.32M	-$28.51M
YoY Change	68.4%	195.72%	4875.92%
Depreciation, Depletion And Amortization	$500.0K	$4.831M	$300.0K
YoY Change	-16.67%	1510.33%	-73.45%
Cash From Operating Activities	-$5.944M	-$21.25M	-$41.92M
YoY Change	-77.92%	-49.31%	-1730.49%
INVESTING ACTIVITIES
Capital Expenditures		$132.0K	$1.132M
YoY Change		-88.34%	621.02%
Acquisitions		-$831.0K	$54.89M
YoY Change		-101.51%
Other Investing Activities	-$727.0K	-$2.069M	-$55.94M
YoY Change	-93.27%	-96.3%	-34.93%
Cash From Investing Activities	-$587.0K	-$2.201M	-$57.16M
YoY Change	-95.96%	-96.15%	-33.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	939.0K	20.26M	-$230.0K
YoY Change	-105.11%	-8909.57%	-100.08%
NET CHANGE
Cash From Operating Activities	-5.944M	-21.25M	-$41.92M
Cash From Investing Activities	-587.0K	-2.201M	-$57.16M
Cash From Financing Activities	939.0K	20.26M	-$230.0K
Net Change In Cash	-5.592M	-3.190M	-$99.11M
YoY Change	-90.65%	-96.78%	-152.14%
FREE CASH FLOW
Cash From Operating Activities	-$5.944M	-$21.25M	-$41.92M
Capital Expenditures		$132.0K	$1.132M
Free Cash Flow		-$21.38M	-$43.05M
YoY Change		-50.33%	-1883.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2023Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense
CY2023Q1	us-gaap	Due From Other Related Parties Current DueFromOtherRelatedPartiesCurrent	539000	usd
CY2022Q4	us-gaap	Due From Other Related Parties Current DueFromOtherRelatedPartiesCurrent	899000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	75513000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	114038000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11414000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9072000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	156090000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52768000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	51371000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	37775000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19626000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15979000	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	10284000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2974000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2885000	usd
CY2023Q1	us-gaap	Assets Assets	316988000	usd
CY2022Q4	us-gaap	Assets Assets	242801000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	57598000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	29699000	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	11982000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	9848000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6024000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4167000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2498000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2749000	usd
CY2023Q1	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	2443000	usd
CY2022Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	2376000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3984000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4082000	usd
CY2023Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	2014000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	2021000	usd
CY2023Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	6223000	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	7270000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1650000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3928000	usd
CY2023Q1	idex	Warrant Liability WarrantLiability	18553000	usd
CY2022Q4	idex	Warrant Liability WarrantLiability	0	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15174000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10721000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	128143000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	76861000	usd
CY2023Q1	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	1894000	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	1957000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15288000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12273000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	60721000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4203000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3000000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2022000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2147000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	212271000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	96238000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	916448791	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	598286221	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	790072216	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	598286221	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	916000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	597000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1041955000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1004082000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-951099000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-866450000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5048000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6104000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	86724000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	132125000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	3056000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4326000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	89780000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	136451000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	316988000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	242801000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10562000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25391000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	11131000	usd
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	25371000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-569000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	20000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46245000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	37095000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4625000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1014000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	44113000	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	81000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4510000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1285000	usd
CY2023Q1	idex	Other General Expense Including Contingent Consideration Adjustment OtherGeneralExpenseIncludingContingentConsiderationAdjustment	-12596000	usd
CY2022Q1	idex	Other General Expense Including Contingent Consideration Adjustment OtherGeneralExpenseIncludingContingentConsiderationAdjustment	-131000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	86897000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	39344000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-87466000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-39324000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	340000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	763000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1349000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	579000	usd
CY2023Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	0	usd
CY2022Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	10965000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2382000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-86093000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-28132000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2985000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-378000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2784000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1338000	usd
CY2023Q1	idex	Net Income Loss Available To Common Stockholders Basic Including Portion Attributable To Noncontrolling Interest NetIncomeLossAvailableToCommonStockholdersBasicIncludingPortionAttributableToNoncontrollingInterest	-85892000	usd
CY2022Q1	idex	Net Income Loss Available To Common Stockholders Basic Including Portion Attributable To Noncontrolling Interest NetIncomeLossAvailableToCommonStockholdersBasicIncludingPortionAttributableToNoncontrollingInterest	-29092000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1575000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-580000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-84317000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-28512000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	731001467	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	731001467	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	497359747	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	497359747	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-85892000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-29092000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1361000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1209000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-84531000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27883000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1270000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-296000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83261000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27587000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	136451000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2470000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	214000	usd
CY2023Q1	idex	Adjustments To Additional Paid In Capital Preferred Stock Warrants AdjustmentsToAdditionalPaidInCapitalPreferredStockWarrants	17402000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	26308000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3377000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	354000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	8850000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	15157000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	0	usd
CY2023Q1	idex	Profit Loss Including Portion Attributable To Noncontrolling Interest ProfitLossIncludingPortionAttributableToNoncontrollingInterest	-85892000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1361000	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	916448791	shares
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	89780000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	365368000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2355000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	435000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	83000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	66000	usd
CY2022Q1	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	236000	usd
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	24778000	usd
CY2022Q1	idex	Profit Loss Including Portion Attributable To Noncontrolling Interest ProfitLossIncludingPortionAttributableToNoncontrollingInterest	-29092000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1209000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	364800000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-85892000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-29092000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2470000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2355000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4831000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1285000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1325000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	878000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	226000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	718000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	712000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-2985000	usd
CY2022Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-378000	usd
CY2023Q1	idex	Issuance Of Common Stock And Warrants For Professional Fees IssuanceOfCommonStockAndWarrantsForProfessionalFees	3073000	usd
CY2022Q1	idex	Issuance Of Common Stock And Warrants For Professional Fees IssuanceOfCommonStockAndWarrantsForProfessionalFees	749000	usd
CY2023Q1	idex	Gain Loss On Extinguishment Of Liabilities GainLossOnExtinguishmentOfLiabilities	-151000	usd
CY2022Q1	idex	Gain Loss On Extinguishment Of Liabilities GainLossOnExtinguishmentOfLiabilities	-43000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-12946000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-131000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	44113000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	81000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-176000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2784000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1338000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-180000	usd
CY2023Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	0	usd
CY2022Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	10965000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1968000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1183000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-942000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6428000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6388000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3967000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	14235000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	6624000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-354000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1933000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	426000	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	101000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1494000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6991000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21251000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41920000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	132000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1132000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	85000	usd
CY2023Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
CY2022Q1	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	-417000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-831000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	54889000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2900000	usd
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	514000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	usd
CY2022Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	120000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2201000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57157000	usd
CY2023Q1	idex	Proceeds From Warrant Exercise Issuance Of Common Stock And Stock Options Exercised ProceedsFromWarrantExerciseIssuanceOfCommonStockAndStockOptionsExercised	3129000	usd
CY2022Q1	idex	Proceeds From Warrant Exercise Issuance Of Common Stock And Stock Options Exercised ProceedsFromWarrantExerciseIssuanceOfCommonStockAndStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1400000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	9850000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2000000	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	7500000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1725000	usd
CY2022Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	633000	usd
CY2022Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	147000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2656000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	83000	usd
CY2023Q1	idex	Payment Of Finance Lease Obligations PaymentOfFinanceLeaseObligations	53000	usd
CY2022Q1	idex	Payment Of Finance Lease Obligations PaymentOfFinanceLeaseObligations	0	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2000000	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20262000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-230000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	141000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	201000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3049000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-99106000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21929000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	269863000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18880000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170757000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	116000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	idex	Stock Issued Acquisitions StockIssuedAcquisitions	26308000	usd
CY2022Q1	idex	Stock Issued Acquisitions StockIssuedAcquisitions	0	usd
CY2023Q1	idex	Stock Issued During Period Value For Repayment Of Convertible Note And Accrued Interest StockIssuedDuringPeriodValueForRepaymentOfConvertibleNoteAndAccruedInterest	15157000	usd
CY2022Q1	idex	Stock Issued During Period Value For Repayment Of Convertible Note And Accrued Interest StockIssuedDuringPeriodValueForRepaymentOfConvertibleNoteAndAccruedInterest	0	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	685000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023Q1	idex	Purchases Of Intangibles With Unpaid Costs Accrued In Accounts Payable PurchasesOfIntangiblesWithUnpaidCostsAccruedInAccountsPayable	40000	usd
CY2022Q1	idex	Purchases Of Intangibles With Unpaid Costs Accrued In Accounts Payable PurchasesOfIntangiblesWithUnpaidCostsAccruedInAccountsPayable	0	usd
CY2023Q1	idex	Stock Issued Conversion Of Preferred Stock StockIssuedConversionOfPreferredStock	8850000	usd
CY2022Q1	idex	Stock Issued Conversion Of Preferred Stock StockIssuedConversionOfPreferredStock	0	usd
CY2023Q1	idex	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Since Inception RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilitySinceInception	320000	usd
CY2022Q1	idex	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Since Inception RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilitySinceInception	6746000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified for comparative purposes to conform to the current-period financial statement presentation.</span></div>
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9312000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12043000	usd
CY2023Q1	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	11417000	usd
CY2022Q4	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	10868000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17273000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11043000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10649000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	5708000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	27353000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	28246000	usd
CY2023Q1	idex	Inventory Serving As Collateral For Short Term Borrowing InventoryServingAsCollateralForShortTermBorrowing	6100000	usd
CY2022Q4	idex	Inventory Serving As Collateral For Short Term Borrowing InventoryServingAsCollateralForShortTermBorrowing	6100000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	700000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	600000	usd
CY2021Q2	us-gaap	Cost Method Investments CostMethodInvestments	7500000	usd
CY2022Q4	us-gaap	Variable Interest Entity Primary Beneficiary Maximum Loss Exposure Amount VariableInterestEntityPrimaryBeneficiaryMaximumLossExposureAmount	39100000	usd
CY2023Q1	idex	Debt Instrument Number Of Covenants Breached DebtInstrumentNumberOfCovenantsBreached	2	covenant
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18900000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	75600000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15200000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4000000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	9900000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-84300000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-951100000	usd
CY2023Q1	idex	Proceeds From Sale Of Shares And Issuance Of Notes ProceedsFromSaleOfSharesAndIssuanceOfNotes	20300000	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collection Of Longterm Investments ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments	50000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10562000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25391000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10562000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25391000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	700000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2100000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	60513000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	48913000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Foreign Currency Translation FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation	176000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11776000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	180000000.0	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	10581000	usd
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	25411000	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	73012000	usd
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	40082000	usd
CY2022Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss	11000000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	1000000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	1200000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11924000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11791000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3274000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2719000	usd
CY2023Q1	idex	Property Plant And Equipment After Depreciation PropertyPlantAndEquipmentAfterDepreciation	8650000	usd
CY2022Q4	idex	Property Plant And Equipment After Depreciation PropertyPlantAndEquipmentAfterDepreciation	9072000	usd
CY2023Q1	idex	Property Plant And Equipment Construction In Progress PropertyPlantAndEquipmentConstructionInProgress	2764000	usd
CY2022Q4	idex	Property Plant And Equipment Construction In Progress PropertyPlantAndEquipmentConstructionInProgress	0	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11414000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9072000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	700000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	300000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	us-gaap	Number Of Reporting Units NumberOfReportingUnits	8	businessunit
CY2022Q4	us-gaap	Goodwill Goodwill	37775000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	13020000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	576000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	51371000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	173739000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9263000	usd
CY2023Q1	idex	Finite Lived Intangible Assets Impairment Loss FiniteLivedIntangibleAssetsImpairmentLoss	8411000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156065000	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	174264000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9263000	usd
CY2023Q1	idex	Intangible Assets Excluding Goodwill Impairment Loss IntangibleAssetsExcludingGoodwillImpairmentLoss	8911000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	156090000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	77368000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7875000	usd
CY2022Q4	idex	Finite Lived Intangible Assets Impairment Loss FiniteLivedIntangibleAssetsImpairmentLoss	17250000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52243000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	77893000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7875000	usd
CY2022Q4	idex	Intangible Assets Excluding Goodwill Impairment Loss IntangibleAssetsExcludingGoodwillImpairmentLoss	17250000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52768000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4100000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	15766000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	18764000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	16651000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14773000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	13168000	usd
CY2023Q1	idex	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	76943000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156065000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11749000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11781000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	15669000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	15176000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1894000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1957000	usd
CY2023Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.076
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.081
CY2023Q1	idex	Debt Instrument Number Of Covenants Breached DebtInstrumentNumberOfCovenantsBreached	2	covenant
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	98000000	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2400000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2400000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	33240364	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.17
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1563574	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.07
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	222292	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.41
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31454498	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.19
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M29D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	idex	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber	21292622	shares
CY2023Q1	idex	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageExercisePrice	1.42
CY2023Q1	idex	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm	P7Y1M28D
CY2023Q1	idex	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue	0	usd
CY2023Q1	idex	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber	10161876	shares
CY2023Q1	idex	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingWeightedAverageExercisePrice	0.71
CY2023Q1	idex	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingWeightedAverageRemainingContractualTerm	P9Y2M23D
CY2023Q1	idex	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3500000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M4D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2000000	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2200000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.23
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0169
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0212
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.29
CY2023Q1	idex	Weighted Average Remaining Life Of Warrants Outstanding WeightedAverageRemainingLifeOfWarrantsOutstanding	P4Y9M
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	98039216	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10000000	shares
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-84317000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28512000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	731001467	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	497359747	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	731001467	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	497359747	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	497359747	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2220314000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	147296000	shares
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
CY2023Q1	idex	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Offset Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceOffsetPercent	0.80
CY2023Q1	idex	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Offset Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceOffsetPercent	0.80
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000000	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	600000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	300000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	300000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	61548000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	867000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	73628000	usd

Files In Submission

Name	View Source	Status
0001628280-23-027525-index-headers.html	Edgar Link	pending
0001628280-23-027525-index.html	Edgar Link	pending
0001628280-23-027525.txt	Edgar Link	pending
0001628280-23-027525-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
idex-20230331.htm	Edgar Link	pending
idex-20230331.xsd	Edgar Link	pending
idex-20230331xexx311.htm	Edgar Link	pending
idex-20230331xexx312.htm	Edgar Link	pending
idex-20230331xexx321.htm	Edgar Link	pending
idex-20230331xexx322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
idex-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
idex-20230331_def.xml	Edgar Link	unprocessable
idex-20230331_pre.xml	Edgar Link	unprocessable
idex-20230331_lab.xml	Edgar Link	unprocessable
idex-20230331_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IDEX
IDEANOMICS, INC. Stock $idex

2023 Q3 Form 10-Q Financial Statement

#000162828023027525 Filed on August 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDEX IDEANOMICS, INC. Stock $idex

2023 Q3 Form 10-Q Financial Statement

#000162828023027525 Filed on August 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDEX
IDEANOMICS, INC. Stock $idex